机构：[1]Department of Radiology and Nuclear Medicine,VU University Medical Center, Amsterdam[2]Department of Neurology,VU University Medical Center, Amsterdam[3]Department of Epidemiology and Biostatistics,VU University Medical Center, Amsterdam,[4]Department of Radiology, Erasmus Medical Centre, Rotterdam, The Netherlands,[5]Department of Radiology, Xuanwu Hospital, Capital Medical University, Beijing, China,放射科首都医科大学宣武医院[6]Department of Radiology, Medical Center Haaglanden, The Hague, The Netherlands,[7]Multiple Sclerosis Clinical Development Group, Biogen, Cambridge, MA, United States
第一作者机构：[1]Department of Radiology and Nuclear Medicine,VU University Medical Center, Amsterdam
通讯作者：
通讯机构：[1]Department of Radiology and Nuclear Medicine,VU University Medical Center, Amsterdam
推荐引用方式(GB/T 7714)：
M.P. Wattjes,M.T. Wijburg,A. Vennegoor,et al.Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients[J].MULTIPLE SCLEROSIS JOURNAL.2015,21:
APA：
M.P. Wattjes,M.T. Wijburg,A. Vennegoor,B.I. Witte,S.D.Roosendaal...&J. Killestein.(2015).Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.MULTIPLE SCLEROSIS JOURNAL,21,
MLA：
M.P. Wattjes,et al."Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients".MULTIPLE SCLEROSIS JOURNAL 21.(2015)
